Sabina Comis

• Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London, and Milan, in connection with a long-term strategic and financial partnership in life sciences with Apollo, a global, high-growth alternative asset manager.
  
• Vestiaire Collective, a leading global online marketplace for desirable pre-loved fashion, in the tax structuring of its acquisition of Tradesy, Inc., a leading peer-to peer resale platform for luxury fashion in the United States.
  
• ArchiMed, a leading investment firm exclusively dedicated to the healthcare sector, in connection with the structuring of the purchase of a majority stake in CARSO, a French leader in analytical services, through its €1 billion MED Platform I fund.
  
• Five T Hydrogen, a clean hydrogen enabling investment platform, on the tax structure of the Hy24 project, a joint venture between Five T Hydrogen and Ardian, a world-leading private investment house.
  
• Affluent Medical, a French medtech company specialising in urology and cardiology, in connection with the tax structuring of its IPO on the Euronext Paris regulated market.
  
• Natixis, a French corporate and investment bank, in connection with the tax structuring of the acquisition by Powerhouse Habitat of a residential portfolio from EDF.
  
• Edmond de Rothschild REIM in connection with the tax structuring of the acquisition and conversion of a commercial property in the center of Paris into a residential property.
  
• ING Bank in connection with the tax structuring of the acquisition of eleven logistics platforms.
  
• Abivax, a biotechnological company listed on the Euronext market, in connection with the tax aspects related to its €85m financing through a share capital increase and the issuance of convertible bonds.
  
• Blisce, a transatlantic management company founded by Alexandre Mars, on the structuring of its second fund, Blisce Fund II, which has obtained Growth Tech label Tibi as part of a government initiative in the technology space, and which aims to raise €300 million.
• Domnin de KERDANIEL and Filippo MONTELEONE in connection with the acquisition of Essling Capital, an independent alternative investment firm.
• Crown Holdings, Inc. in its definitive agreement to sell its European Tinplate business to KPS Capital Partners, LP.
• Certares, an American private equity fund, in connection with its investment in the group Voyageurs du Monde, the French leader of tailored travel and adventure travel.
• HysetCo, a pioneer in hydrogen energy which owns the world’s largest fleet of hydrogen taxis operated by Hype, in connection with the acquisition of Slota Group, a long-standing Parisian taxi operator.
• Elsan, French private clinics and hospitals operator, and KKR, a leading U.S. private equity firm, in connection with the exclusive agreement for the acquisition of the C2S group of generalist clinics from Eurazeo Patrimoine.
• KKR on the tax structuring of the acquisition, alongside other co-investors, of the Elsan group for €3.3 billion.
• The shareholders of CTRS, a French pharmaceutical company, in connection with its OBO transaction.
• The founders and directors of 7Hugs Labs, the business angels, Karista, Kima Ventures and NovX Capital on the sale of the entire share capital of 7Hugs Labs, a French tech company to Qorvo, a NASDAQ-listed U.S. company specializing in innovative radio frequency solutions. 
• ArchiMed, a European investment firm specialized in the Healthcare industries, in the partial sale to Warburg Pincus as well as on its reinvestment, alongside Warburg Pincus, in the Polyplus group.
• Mérieux Equity Partners in connection with its investment in the LBO on Ceva, the world's fifth largest veterinary pharmaceutical laboratory.
• Compagnie du Ponant, the leading luxury cruise company and subsidiary of Artemis, in connection with the tax structuring of the acquisition of Paul Gauguin Cruises from the Pacific Beachcomber hotel group.
• Sofinnova Partners, Bpifrance and IXO Private Equity on their investment into Microphyt, a company specializing in natural solutions based on microalgae for nutrition and well-being.
• Caravelle, a French investment company, in connection with its acquisition of Luneau Technology Group, a specialist in eye care professional products.
• Biomunex Pharmaceuticals, a biopharmaceutical company focused on providing immuno-therapeutics, in its licensing agreement with Sanofi.
• Generali, one of the world’s leading insurers, on its acquisition of Sycomore Asset Management, a pioneer in the Environmental, Social and Governance (ESG) and Socially Responsible Investment (SRI) in Europe.
• MedinCell, a technology-based pharmaceutical company, on its IPO on Euronext in Paris.
• Certares, a private equity firm focusing on the travel and tourism industries, on its investment in Marietton group, a leading tour operator and travel agent in France.
• Astorg on the acquisition of a stake in Echosens, innovative French high-technology company, from Cathay Capital Private Equity SAS, OrbiMed Advisors LLC and several minority shareholders.
• Partech Partners, the management company of Partech International Ventures VII, in reaching its hard cap of €400 million for the seventh generation of its historical venture capital fund.
• Crown Holdings on its completed US$3.91 billion acquisition of Signode Industrial Group LLC, a global provider of transit packaging systems and solutions, from the Carlyle Group.
• French and international private equity funds on large and medium cap LBO structurings (often including multi-sponsors).
• The first French private equity fund coupled with a French type of endowment fund on its tax and legal structuring.
• Financial institutions on tax and regulatory matters in relation to their fund vehicles.
• One of the world's leading manufacturer and provider of electronic solutions on various French tax dispute resolutions.
• Regulated management companies and investment advisers on their internal restructurings or their purchase of third-party players.
• The first dedicated European provider of mezzanine and preferred equity financing for private equity portfolios on its tax and legal structuring.
• The first French regulated and leveraged investment vehicle for the purchase of discounted debt on its tax and legal structuring.

Includes matters handled at Dechert or prior to joining the firm.

• Liquidity, but who pays the price? A candid take on three tools in the toolkit – IPEM (September 10, 2026)
• Managing conflicts of interest when launching a continuation vehicle – IPEM (September 26, 2025)
• Liquidity Rush – IPEM (September, 11 2024) 
• Democratisation of private markets: the next frontier – Private Equity International conference (November 28, 2023)
• Perception des LPs au regard des outils de liquidité utilisés par leur GP – Dechert and 17Capital Roundtable (November 22, 2023)
• The Retailization of Private Equity in Europe – A Growing Phenomenon – Dechert Committed Capital (November 2, 2023)
• Big picture on secondaries, and The trends to watch in the GP market – IPEM (September 19, 2023)
• How do asset management companies finance and develop themselves today? – Private Equity France, L’Agefi (April 4, 2023)
• What Next for Alternatives? – Dechert Fund Congress (February 9, 2023)
• 2023 Global Private Equity Outlook – Women in Private Markets Summit, PEI (December 15, 2023)
• Secondaries: Deep dive on the next stage of the market’s evolution – Dechert webinar (November 30, 2023)
• European Retailization – Dechert Committed Capital - Global Private Equity Podcast (November 2, 2022)
  
• Liquidity and other regulatory protective initiatives and Retailisation of alternative asset classes – How does this fit together in the new green world of SFDR? – Annual Luxembourg Investment Funds Conference (October 20, 2022)
• Du "bridge financing" au financement de portefeuille – Dechert and 17Capital Roundtable (September 29, 2022)
• ATAD 3 Tax Developments - Dechert Private Funds Annual Legal Retreat (September 15-16, 2022)
  
• 17th annual NYU Stern Private Equity & Venture Capital Conference – Webinar The Stern PEVC Club (April 01, 2022)
• Shaping the European PE industry – Harvard Business School annual VCPE Conference (February 06, 2021).
• Kayo Women’s Private Equity Boot Camp – Kayo’s annual Conference (January 22, 2021)
  
• Fund formation in France, Luxembourg or Ireland: What's best for you? – Dechert LLP, Paris (June 20, 2019)
• More than just looking for profit – Private Equity International's France roundtable, Paris (June 03, 2019)
• Investisseurs Allemands et Sociétés de Gestion Françaises – Dechert's roundtable, Paris (February 05, 2019)
• Credit Funds: A Global Perspective on Evolving Structures – Dechert's roundtable, London (January 24, 2018)
• French Private Equity Conference "GP Fundraising: Executing the best fundraising practices" – Private Equity Insights, Paris (January 18, 2018)
• Loi de Finances et élection présidentielle : quelle fiscalité en 2017 et après ? – Dechert's conference series, Paris (January – February, 2017)

• La SLP est devenue un véhicule incontournable - Agefi (March 19, 2026)
• Fonds de continuation et Lead Investors étrangers : la ligne de crête des 25% – Capital Finance – (September 22, 2025)
• Loi Industrie Verte : Nouvelles opportunités en matière de contrats d'assurance-vie, de capitalisation et de plans d'épargne retraite - Private Equity Magazine - (February 17, 2025)
• Rétrospective 2024 : Évolutions et perspectives pour la gestion d'actifs en 2025 - Capital Finance - (January 21, 2025)
• Société de libre partenariat "spéciale" : quelles opportunités fiscales pour les investisseurs ? - Capital Finance - (September 9, 2024)
• France: Investment Funds 2024 - Chambers Global Practice Guides - (February 8, 2024)
• Réforme ELTIF 2.0 : favoriser le financement de l’économie réelle par les investisseurs de détail - Revue Droit & Affaires - (January 29, 2024)
• Localisation des équipes de gestion : la doctrine de l’AMF évolue, mais pas les règles fiscales…– Capital Finance – (January 21, 2024)
• Pas de démocratisation du private equity sans une fiscalité compétitive – Capital Finance – (September 18, septembre 2023)
• Enjeux fiscaux en matière de structuration des opérations de GP-stake – Capital Finance – (January 23, 2023)
• What is on the mind of GPs in 2023 and what French tax hurdles should they anticipate ? – Combuyn – (January 23, 2023)
• Projet de directive DEBRA : le moins bon des deux mondes pour les opérations de LBO – Capital Finance (September 09, 2022)
  
• The Retailisation of Private Equity – International Comparative Legal Guide: Alternative Investment Funds (August 03, 2022)
• Le régime fiscal français du carried interest à l’épreuve des éléments d’extranéité - Éditions JFA – (February 01, 2022)
  
• Nouvelle opportunité d’exonération sur les plus-values de cession – Capital Finance – (November 25, 2021)
  
• De la substance au principal purpose test, un changement de paradigme dans la structuration des opérations de LBO internationales – Capital Finance – (September 06, 2021)
  
• Typologie des fonds et règlementation – Actes pratiques & stratégie patrimoniale - LexisNexis – (June 01, 2021)
  
• Les aspects fiscaux du carried interest un enjeu capital en matière de structuration de fonds – Actes pratiques & stratégie patrimoniale, LexisNexis – (June 01, 2021)
• Apport-cession : le LBO laissé pour compte ? - Capital Finance - (March 11, 2019)
• France Welcomes Foreign Asset Managers With Softened Tax Treatment of Carried Interest - Hedge Fund Law Report - (December 6, 2018)